【正文】
in patients receiving chronic anticoagulation therapy. Am Heart J, 2004。147(1):315.9. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoaulants: mechanism of action, clinical effectiveness, and optimal therapeutical range. Chest, 2001。119(1 Suppl):8S21S.10. Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet, 2004。43(14):963981.11. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med, 2003。163(8):901908.12. Shpitz B, Plotkin E, Spindel Z, et al. Should aspirin therapy be withheld before insertion and/or removal of a permanent peritoneal dialysis catheter? Am Surg, 2002。68(9):762764.13. Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomized double blind study. Lancet, 2000。355(9212): 12891290.14. Molenaar IQ, Porte RJ. Aprotinin and thromboembolism in liver transplantation: is there really a causal effect? Anesth Analg, 2002。94(5):13671368.15. Bombeli T, Spahn DR Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anaesth, 2004。93(2):275287.16. Iselin BM, Willimann PF, Seifert B, et al. Isolated reduction of haematocrit does not promise in vitro blood coagulation. Br J Anaesth, 2001。87(2):246249.17. Friederich PW, Henny CP, Messelink EJ,et al. Effect of rebinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a doubleblind placebocontrolled randomised trial. Lancet, 2003。361(9353):201205.9 /